Related Experiment Video
Updated: Nov 22, 2025

Author Spotlight: Functionalizing Metal-Organic Frameworks: Advancements, Challenges, and the Power of Post-Synthetic Ligand Exchange
Published on: June 23, 2023
A New, Second Generation Trithiol Bifunctional Chelate for 72,77As: Trithiol(b)-(Ser)2-RM2
Firouzeh Najafi Khosroshahi, Yutian Feng, Li Ma
1Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri 65201, United States.
New radiopharmaceuticals using arsenic isotopes show promise for cancer theranostics. Researchers developed a novel arsenic-labeled bioconjugate for targeted imaging and therapy of gastrin-releasing peptide receptor-expressing tumors.
Area of Science:
- Nuclear chemistry
- Radiopharmaceutical science
- Oncology
Background:
- Trithiol chelates are effective for labeling radioarsenic isotopes like 72As and 77As.
- These radioarsenic compounds can be developed into theranostic radiopharmaceuticals for positron emission tomography (PET) imaging and therapy.
- The gastrin-releasing peptide (GRP) receptor is a target for certain cancers.
Purpose of the Study:
- To synthesize and characterize a trithiol(b)-(Ser)2-RM2 bioconjugate and its arsenic complex.
- To evaluate the radiolabeling efficiency, stability, and GRP receptor binding affinity of the arsenic-trithiol bioconjugate.
- To perform preliminary biodistribution studies of the radiolabeled compound in mice.
Main Methods:
- Synthesis and characterization of a trithiol(b)-(Ser)2-RM2 bioconjugate.
- Radiolabeling with no-carrier-added 77As.
- In vitro stability assays and IC50 cell binding studies in PC-3 cells.
- High-performance liquid chromatography (HPLC) purified biodistribution studies in normal mice.
Main Results:
- The trithiol(b)-(Ser)2-RM2 bioconjugate was successfully synthesized and formed an arsenic complex.
- Radiolabeling with 77As achieved over 95% radiochemical yield, with the radiolabeled complex remaining stable for over 48 hours.
- In vitro studies showed high affinity for the gastrin-releasing peptide (GRP) receptor (low nanomolar range) in PC-3 cells.
- Biodistribution studies indicated pancreatic uptake and hepatobiliary clearance of the 77As-labeled compound.
Conclusions:
- The developed arsenic-trithiol bioconjugate is a promising platform for creating theranostic radiopharmaceuticals.
- The compound demonstrates efficient radiolabeling, stability, and specific binding to the GRP receptor.
- Further investigation is warranted for its potential application in cancer imaging and therapy.
More Related Videos
Related Concept Videos
Preparation and Reactions of Sulfides
Chirality at Nitrogen, Phosphorus, and Sulfur
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
Hybridization of Atomic Orbitals I
Radical Substitution: Allylic Bromination
Preparation and Reactions of Thiols
Electrophilic Addition to Alkynes: Halogenation
Halogenation is another class of electrophilic addition reactions where a halogen molecule gets added across a π bond. In alkynes, the presence of two π bonds allows for the addition of two equivalents of halogens (bromine or chlorine). The addition of the first halogen molecule forms a trans-dihaloalkene as the major product and the cis isomer as the minor product. Subsequent addition of the second equivalent yields the tetrahalide.

